Deals channel feed – Endpoints News

Deals channel feed

Cedars-Sinai partners with Redesign Health to build health tech startups

3 days ago

Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal

4 days ago

Function buys Ezra, creating one-stop shop for preventive testing and scans

5 days ago

After hunt for alternatives, Kronos Bio selects Tang Capital's Concentra for a deal

Last week

Amicus grabs Dimerix’s rare kidney disease drug for $30M upfront

Last week

Teladoc buys virtual therapy startup UpLift for $30M

Last week

Updated: Novartis to buy Regulus Therapeutics for up to $1.7B

Last week

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

Last week

New fund will pressure flailing biotechs, as investor frustration boils over

3 weeks ago

Merck KGaA closes in on SpringWorks deal at $3.5B price point

3 weeks ago

Bristol Myers CEO signals dealmaking will be a top priority in 2025

3 weeks ago

Roche CEO warns that tariffs could impact dealmaking

3 weeks ago

China’s biotech market is staging a comeback that US biotech can only wish for

3 weeks ago

Repertoire inks autoimmune deal with Genentech as it eyes a return to the clinic

3 weeks ago

Boehringer taps Dutch biotech for ALT positive cancer pact exceeding $573M in biobucks

3 weeks ago

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

4 weeks ago

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

4 weeks ago

Ayrmid misses deadline for detailed offer to top private equity bid for bluebird

4 weeks ago

GeneDx to buy Fabric Genomics for up to $51M

4 weeks ago

Exclusive: A small biotech will bring Roche's Angelman drug back to life

4 weeks ago

Merck explores potential of oral peptides in deal with Austrian biotech

4 weeks ago

What's Pfizer's next move after shelving its oral obesity drug danuglipron?

4 weeks ago

Tempest seeks strategic alternatives to fund Phase 3 liver cancer trial

Last month

Market turmoil is tanking biotech M&A and IPOs. Here's the playbook startups will use to survive

Last month

12 3 4 Next page Last page